title: Microwave assisted synthesis of novel pyrazolone derivatives attached to a pyrimidine moiety and evaluation of their anti-inflammatory, analgesic and antipyretic activities.
abstract: In the present research work, the motto was to develop new chemical entities as potential anti-inflammatory, analgesic and antipyretic agents. Various 4-(2-amino-6-(substituted)pyrimidin-4-yl)-3-methyl-1-(substituted)-1H-pyrazol-5(4H)-one derivatives (5a-5j) and their Schiff bases (6a-6j) were synthesized. The newly synthesized compounds were characterized by TLC and spectral data. The compounds containing pyrazolone and amino pyrimidine as basic moieties (5a-5j), were screened for their anti-inflammatory, analgesic and antipyretic activities, compounds 5a, 5c-5f, 5h exhibited activities nearly similar to the standard. The pharmacological studies reveal that the presence of 4-hydroxy, 4-methoxy, 4-(N,N-dimethylamino) or 2-hydroxy groups on phenyl ring at C6 of amino pyrimidine exhibits anti-inflammatory, analgesic and antipyretic activities nearly similar to the standard and substitutions like 4-chloro, 2-nitro, 3-nitro or 4-nitro on same phenyl ring lead to a decrease in activities.
authors: Medicinal Chemistry Research Laboratory, Acharya & B.M. Reddy College of Pharmacy, Bangalore 560 090, Karnataka, India.
authors: Rishikesh V
authors: RV
authors: Antre
authors: A
authors: A
authors: Cendilkumar
authors: Divakar
authors: D
authors: Goli
authors: Ganesh S
authors: GS
authors: Andhale
authors: Rajesh J
authors: RJ
authors: Oswal
keywords: Amino pyrimidine; Analgesic; Anti-inflammatory; Antipyretic; Pyrazolone; Schiff bases
references: Eur J Pharmacol. 2002 Sep 13;451(2):141-7
references: 12231383
references: Nat Rev Drug Discov. 2006 Jul;5(7):549-63
references: 16773072
references: Eur J Med Chem. 2009 Nov;44(11):4622-36
references: 19647903
references: Farmaco. 1998 Jan;53(1):55-7
references: 9543727
references: J Med Chem. 2009 Jan 22;52(2):574-8
references: 19113954
references: Curr Drug Targets. 2001 Mar;2(1):79-106
references: 11465540
references: Arch Pharm (Weinheim). 2007 Sep;340(9):476-82
references: 17647214
references: Eur J Med Chem. 2006 Feb;41(2):155-65
references: 16375992
references: J Med Chem. 2008 Jul 24;51(14):4122-49
references: 18578517
references: Eur J Med Chem. 2009 Nov;44(11):4690-4
references: 19646797
references: Eur J Med Chem. 2009 Sep;44(9):3760-4
references: 19535179
references: Proc Soc Exp Biol Med. 1962 Dec;111:544-7
references: 14001233
references: J Pharmacol Exp Ther. 1953 Mar;107(3):385-93
references: 13035677
references: Eur J Pharmacol. 2005 Dec 28;528(1-3):37-42
references: 16324698
references: J Pharmacol Exp Ther. 1997 May;281(2):921-7
references: 9152402
references: J Med Chem. 2007 Oct 18;50(21):5053-6
references: 17850126
references: Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):85-93
references: 18221078
references: J Neurosci Res. 1998 Oct 1;54(1):1-6
references: 9778144
references: Eur J Med Chem. 2008 Oct;43(10):2122-9
references: 18255196
references: Eur J Med Chem. 2007 Jun;42(6):823-40
references: 17331622
references: J Med Chem. 2008 Jan 10;51(1):4-16
references: 18072718
references: Bioorg Med Chem. 2006 Jan 1;14(1):9-16
references: 16263294
references: Eur J Med Chem. 2009 Oct;44(10):3852-7
references: 19423195
references: J Pharmacol Exp Ther. 1994 Mar;268(3):1597-604
references: 8138971
references: J Med Chem. 2009 Jul 23;52(14):4200-9
references: 19489590
references: J Med Chem. 2008 Sep 25;51(18):5758-65
references: 18800767
references: Farmaco. 2003 Sep;58(9):795-808
references: 13679172